Alzheimer blood biomarkers Clinical Trials
Conditions / Alzheimer blood biomarkers
Delta Trials records 4 clinical trials for Alzheimer blood biomarkers in its publicly accessible dataset. From the full dataset, 3 actively seeking eligible participants and 0 trials have reached completion. This research is conducted across 8 study locations around the world. An additional 1 trial are active but not currently open for enrollment. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, with history tracked across multiple versions.
Trial Status
4
Total Trials
3
Recruiting
0
Completed
1
Other Active
0
Terminated since 2020
8
Study Locations
Browse by location (8 total)
- Donostia / San Sebastian, Spain 1 trialAll trials in Donostia / San Sebastian, Spain
- Santander, Spain 1 trialAll trials in Santander, Spain
- Madrid, Spain 1 trialAll trials in Madrid, Spain
- Granada, Spain 1 trialAll trials in Granada, Spain
- Huntsville, United States 1 trialAll trials in Huntsville, United States
- Barcelona, Spain 1 trialAll trials in Barcelona, Spain
- Baton Rouge, United States 1 trialAll trials in Baton Rouge, United States
- Nancy, France 1 trialAll trials in Nancy, France